ONYX PHARMACEUTICALS INC Convertible Securities: Converted or Retired
Securities that convert into the company's stock: convertible notes (from each offering's SEC filings, as on Outstanding Bonds) and convertible preferred stock (from its final term sheet or the 10-K, as on Preferred Shares), newest issue first. Values are as filed.
- 4.00% Convertible Senior Notes due 2016: Type Convertible notes; Issued 2009-08-12; Amount issued $200,000,000; Conversion terms Approximately $39.65 per share of Common Stock. 25.2207 shares of Common Stock per $1,000 principal amount of Notes, subject to adjustment..
| Security | Type | Issued | Amount issued | Conversion terms | Maturity | Converted or retired | Outstanding | Source |
|---|---|---|---|---|---|---|---|---|
| 4.00% Convertible Senior Notes due 2016 | Convertible notes | 2009-08-12 | $200,000,000 | Approximately $39.65 per share of Common Stock. 25.2207 shares of Common Stock per $1,000 principal amount of Notes, subject to adjustment. | 2016-08-15 | Repaid at maturity 2016-08-15: $200,000,000 | $0 | 2009-08-07 |